Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Thalamus Seizure Detection With a Deep Brain Stimulator System

NCT: NCT06700356 · RECRUITING

NCT IDNCT06700356
StatusRECRUITING
Start Date2026-07-01
Completion2027-05
SponsorMayo Clinic (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to determine the feasibility of chronic ambulatory thalamus seizure detection. The sensitivity, specificity, and false alarm rate of thalamus seizure detection will be calculated using recordings from a deep brain stimulation system, assessed relative to concurrent gold-standard video-EEG monitoring collected in the in-patient setting (epilepsy monitoring unit), in 5 patients with drug resistant epilepsy.

Frequently Asked Questions

What is Thalamus Seizure Detection With a Deep Brain Stimulator System?

Thalamus Seizure Detection With a Deep Brain Stimulator System is a clinical trial registered under NCT06700356. Current status: RECRUITING.

What is the status of NCT06700356?

The current status of NCT06700356 (Thalamus Seizure Detection With a Deep Brain Stimulator System) is: RECRUITING.

When did Thalamus Seizure Detection With a Deep Brain Stimulator System start?

Thalamus Seizure Detection With a Deep Brain Stimulator System started on 2026-07-01.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.